Chronic Kidney Disease Japan Cohort

Message from the Steering Committee and Advisors

CKD-JAC and Dialysis Therapy: Tadao Akizawa M.D.
Professor, Department of Nephrology, Showa University School of Medicine
CKD-JAC and Activity of Japanese Society of Nephrology (JSN): Hirofumi Makino M.D.
Professor, Department of Medicine and Crinical Science,Okayama University.
Ambulatory blood pressure monitoring (ABPM) in Chronic Kidney Disease (CKD): Enyu Imai, M.D., Ph. D
Professor, Department of Nephrology,Osaka University Graduate School of Medicine
We can expect many from CKD Japan Cohort Study (CKD-JAC).: Seiichi Matsuo, MD, PhD
Professor, Department of Nephrology, Nagoya University Graduate School of Medicine
Significance of cooperation between CKD-JAC and CRIC study ; a precedent CKD cohort study in U.S.: Tsuyoshi Watanabe, MD, PhD, FACP
Professor, Department of Internal Medicine III, Fukushima Medical University, School of Medicine
Significance of the QOL (Quality of Life) survey: Kosaku Nitta M.D.
Professor, Department of Medicine, Kidney Center, Tokyo Women’s Medical University
Dr.Feldman: Dr.Harold I Feldman, M.D., M.S.C.E.
Director, Clinical Epidemiology Unit, Centor for Clinical Epidemiology and Biostatistics
Professor of Medicine and Epidemiology Renal-Electrolyne and Hypertension Division
University of Pennsylvania School of Medicine
Dr.Kusek: Dr.John W. Kusek
Director and Senior Scientific Advisor,
Urologic and Renal Clinical Trials, Divisionof Kidney, Urologic and Hematologic
Diseases (DKUHD), National Institute of Diabetes and Digestive and Kidney
Diseases (NIDDK), National Institutes of Health